Ray-Coquard et al developed model for identifying adults with cancer who required blood transfusion following chemotherapy. The authors are members of the ELYPSE 1 Study Group from Lyon, Villejuif, Chambery, Neuilly and Toulouse, France.
Patient selection: age >= 18 years of age, solid tumor and receiving chemotherapy
Endpoint: Severe anemia requiring blood transfusion within 31 days of chemotherapy
Parameters at start of chemotherapy:
(1) ECOG performance scale
(2) hemoglobin
(3) absolute lymphocyte count
Parameter |
Finding |
Points |
ECOG performance scale |
0 or 1 |
0 |
|
2, 3 or 4 |
1 |
hemoglobin |
>= 12 g/dL |
0 |
|
< 12 g/dL |
3 |
absolute lymphocyte count (ALC) |
> 700 per µL |
0 |
|
<= 700 per µL |
1 |
total risk score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum risk score: 0
• maximum risk score: 3
Number of Risk Factors |
Percent Requiring RBC Transfusion |
0 |
1.2% |
1 |
3.8% |
2 or 3 |
11% |
4 or 5 |
30% |
Specialty: Clinical Laboratory, Surgery, general, Anesthesiology, Emergency Medicine, Critical Care